Since the measurements of ultrasonography-diagnosed NAFLD, ALT, AST, GGT, and ALP are well standardized and available in routine clinical practice, these markers can be included in future diabetes prediction algorithms. This evidence concerns the gene GPT and diabetes mellitus.